Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry

OBJECTIVES: New-generation coronary stents including zotarolimus- and everolimus-eluting stents (ZES and EES) have been shown to decrease the risk of restenosis. The purpose of this study was to compare the safety and efficacy of ZES and EES over a 12-month clinical follow up, in routine clinical pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Cardiovasc Dis
Main Authors: Poorhoseini, Hamid Reza, Kassaian, Seyed Ebrahim, Hoseini, Kianoosh, Saroukhani, Sepideh, Salarifar, Mojtaba, Alidoosti, Mohammad, Nematipour, Ebrahim, Haji-Zeinali, Ali Mohammad, Amirzadegan, Alireza, Seyyed Mohammadzadeh, Mir Hossein, Khadem Vatan, Kamal, Aghajani, Hassan, Sheikh Fathollahi, Mahmood, Farrokh-Eslamlou, Hamidreza
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942625/
https://ncbi.nlm.nih.gov/pubmed/26857928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944716629868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados